The differential diagnosis between hepatocellular carcinoma (HCC), cholangiocarcinoma (CC) and metastatic colorectal adenocarcinoma (MCA) may be difficult when only based on morphology ([@R21]).

In fact, a subset of extrahepatic adenocarcinomas of different origin may show a solid "hepatoid" pattern virtually indistinguishable from HCC ([@R15]). On the other hand, the undifferentiated form of HCC may mimic poorly differentiated tumors of different origin, while its tubular and adenoid variants may be indistinguishable from CC or from MCA.

In these cases, immunohistochemical analyses are often required ([@R19]).

The panel of antibodies utilized to solve this differential diagnosis includes: CK8-18 ([@R15]) Hep-Par1 ([@R9]) ([@R25]), glypican 3 (GPC3) ([@R23]) ([@R2]), CK7 ([@R10]) ([@R3]), CK20 ([@R5]), CK19, CEA and Alpha-fetoprotein ([@R14]) ([@R8]).

Immunoreactivity of tumour cells for CK8-18, Hep-Par 1 and GPC3 is considered suggestive of HCC; a diffuse immunoreactivity for CK7 and CK19 is in favour of the diagnosis of CC; a diffuse positivity for CK20 and negativity for CK7 are normally associated with MCA.

Here we report a case of HCC with a peculiar immunohistochemical profile, characterized by the association of the typical immunoreactivity of HCC with a diffuse and strong positivity for CK20, generally considered typical of MCA.

Materials and Methods {#S1}
=====================

Clinical history
----------------

A 65-year-old man was referred to our hospital because of asthenia and jaundice. On clinical examination, a picture of decompensated cirrhosis was evident: edema of the lower extremities, ascites, palpable spleen. Laboratory tests showed an increase in serum levels of transaminases (3--4 times normal values), gammaglutamyltranspeptidase (3 times normal values), and bilirubin (total: 14.8 mg/dL; conjugated: 9.1 mg/dL). Viral markers for HBV and HCV were negative. The patient suffered from alcoholic cirrhosis, diagnosed at the age of 47. Esophago-gastroduodenoscopy revealed esophageal varices. Six months before admission, ultrasonography performed during a surveillance program detected two hyperechogenic space-occupying lesions in the right lobe of the liver, 3 and 2.4 cm in diameter respectively. Computed tomography performed three months later, showed multiple mildly hypodense nodules in the right liver lobe, with a hypervascular pattern suggestive of HCC. On admission, liver ultrasound scan showed a tremendous diffusion of the proliferating nodules throughout the whole liver, with the tendency to occupy the entire organ. Alpha-fetoprotein and carcinoembryonic antigen serum levels were in the normal range. In order to evaluate the irregular nodular areas, echo-guided needle liver biopsy was performed.

Sample preparation
------------------

The needle liver biopsy was formalin-fixed, paraffin-embedded and routinely processed. Immunohistochemical stainings were performed using antibodies against CK8-18 (clone 35β H 11 and clone DC 10, Dako Denmark A/S, Glostrup, Denmark), CK20 (clone K520.8, Dako Denmark A/S, Glostrup, Denmark), CK7 (clone OV-TL 12/30, Dako Denmark A/S, Glostrup, Denmark), CK19 (clone RCK 108, Dako Denmark A/S, Glostrup, Denmark), Hep-Par1 (clone OCH1E5, Dako Denmark A/S, Glostrup, Denmark) and GPC3 (clone 1G12, Biomosaic, Inc, Burlington, VT, USA).

Tissue sections were dewaxed, rehydrated through graded alcohols and pre-treated with heat-induced epitope retrieval in 0,01 M Citrate buffer pH 6.00 (GPC33, Hep-Par1, CK7, CK8 and CK18) or 0,1 M Tris Base/0,01 M EDTA pH 9.00 (CK19 and CK20) for immunohistochemical analyses. Slides were incubated for 30 minutes at room temperature with a 1:200 dilution of a polyclonal anti GPC3 primary antibody and with 1:50 dilutions of monoclonal antibodies directed against the following antigens: Hep-Par1, CK7, CK8, CK18, CK20. Staining procedures were performed by Dako REAL EnVision Detection System Peroxidase (Dako Denmark A/S, Glostrup, Denmark) following the manufacturer\'s instructions.

As a control group, we examined the expression of CK20 in 20 previously diagnosed HCC.

Clinical follow-up
------------------

Five months after liver biopsy, the patient developed hepatic encephalopathy and died.

Results {#S2}
=======

The histological examination of the liver biopsy showed two distinct patterns. Silver stain revealed a completely modified hepatic architecture, due to the presence of diffuse porto-central bridging fibrous septa, associated with regenerating hepatocytes arranged in two-cell-thick trabeculae. Portal tracts and bridging septa often contained a mild inflammatory infiltrate, with rare foci of interface hepatitis. Micro and macrovesicular steatosis was homogeneously distributed throughout the regenerating nodules. Mallory bodies were also detected in the cytoplasm of large hepatocytes with clear cytoplasm. Iron deposition was focally observed in hepatocytes and in Kupffer cells. In the deeper part of the bioptic core, with the interposition of a thin fibrous capsule, we observed the proliferation of neoplastic cells, similar in size and shape to hepatocytes, arranged in two architectural patterns: the trabecular one was characterized by 3--4 cell-tick trabeculae; the adenoid pattern showed smaller cells arranged around a central lumen ([Figure 1](#F1){ref-type="fig"}). Mitotic figures were rare. Nuclear vacuoles and pseudoinclusions were frequently observed. On the basis of the morphological findings, the diagnosis of micro-macronodular cirrhosis with mild activity, compatible with alcoholic aetiology, complicated by well differentiated hepatocellular carcinoma was performed. At immunocytochemistry, the first panel of antibodies applied evidenced a diffuse immunoreactivity of tumor cells for CK8 and CK18, and the absence of immunostaining for CK 7 and CK19. Due to the presence of tumor areas showing an adenoid pattern, with psuedoglandular arrangement of tumor cells, we also immunostained tumor cells for CK20. The result of the staining was straightforward: immunoreactivity for CK20 appeared diffuse in the vast majority of neoplastic cells. The percentage of CK20-positive cells ranged from about 50% in areas with trabecular features up to 90% in tumor zones showing an adenoid pattern ([Figure 2](#F2){ref-type="fig"}). Given the discrepancy among immunohistochemical data obtained applying the first panel, we also tested immunoreactivity of tumor cells for Hep-Par1 and glypican3. The typical granular cytoplasmic reactivity for Hep-Par1 was found in the vast majority of tumor cells as well as in the surrounding liver. The majority of tumor cells were also immunostained by glypican 3, which was completely negative in the surrounding liver. In the control group, 19 out of 20 previously diagnosed HCCs did not show any immunoreactivity for CK20, the latter one evidenced a slight focal positivity in scattered tumor cells.

Figure 1Hepatocellular carcinoma showing a mixed trabecular and adenoid pattern. H&E.

Figure 2Intense cytoplasmic immunoreactivity for CK20 of the majority of tumor cells.

Discussion {#S3}
==========

Although clear criteria for the histological diagnosis of HCC have been established by the [@R6], the differential diagnosis of HCC vs CC and MCA may be not so easy, especially when scant material is available for histology ([@R24]).The report of liver metastases from adenocarcinomas of extrahepatic origin showing hepatoid features, underlines the possibility of diagnostic errors when the diagnosis is only based on morphology ([@R15]). A report from our group of a striking intratumoral variability in HCC, related to morphology and to immunoreactivity of tumor cells, highlights the role of sampling variability as a possible cause of pitfalls in diagnosing HCC ([@R17]). Although poorly differentiated HCC may lose immunoreactivity for CK8 and CK18 ([@R22]), HCC is usually CK8^+^, CK18^+^, CK 7^−^, CK19^−^, CK20^−^ ([@R4]). In clinical practice, the use of CK7/CK20 immunostaining is considered a useful tool in distinguishing HCC (CK7^+^ in 10%; CK20^+^ in 7%) from periferal CC (CK7^+^ in 96%; CK20^+^ in 47%) ([@R16]), non periferal CC (CK7^+^ in 96%; CK20^+^ in 82%) ([@R16]), colorectal carcinoma (CK7+ in 27%; CK20^+^ 94%) ([@R4]), pancreatic cancer (CK7^+^ 94%; CK20^+^ 52%) ([@R4]) and hepatoblastoma (CK7^+^ 26%) ([@R4]) ([@R7]) ([Table 1](#T1){ref-type="table"}). In normal human tissues, CK20

immunoreactivity is restricted to gastric and intestinal epithelium ([@R1]), Merkel cells of the skin ([@R11]), and transitional epithelium ([@R18]), whereas it is absent in the liver. In carcinomas, a diffuse immunoreactivity for CK20 is restricted to a few tumors: colon cancer (90%), Merkel cell tumor (86%), transitional cell carcinoma (68%), gastric carcinoma (56%), and pancreatic carcinoma (56%) ([@R4]).

Table 1CK7/CK20 immunostaining.*CK 7CK 20*HCC10%7%Periferal CC96%47%Non periferal CC96%82%Colorectal carcinoma27%94%Pancreatic cancer94%52%Hepatoblastoma26%n.a.

Here we report a case of HCC showing an immunohistochemical pattern normally considered typical for a metastasis originating from gastrointestinal tract primaries ([@R13]): a diffuse and strong immunoreactivity of the vast majority of tumor cells for CK20. In previous studies CK20 expression has been reported in rare cases of HCC, always restricted to scattered tumor cells, and with such a reactivity never creating diagnostic problems ([@R10]). On the contrary, in our case, the simple application of the panel CK7/CK20 could have excluded the hepatocellular origin of the tumor, in favour of an hepatoid form of colorectal cancer ([@R21]). The reason for this atypical expression of CK20 in our case is unknown. Little information is available concerning the factors that regulate the expression of keratin genes in different cell types, in health and disease ([@R12]). A study from our group on CK20 expression in rat liver demonstrated a strong proliferation of CK20^+^ cells following an experimentally induced cholestasis ([@R5]), showing that keratin expression patterns do not necessarily reflect histogenesis, but may be influenced even by epigenetic factors.

From a practical point of view, the present case confirms previous reports on the complexity of making an unequivocal diagnosis of HCC. The possibility of negativity of small HCCs for Hep-Par 1 ([@R20]), the patchy expression of CK8-18 ([@R22]), the uneven distribution of GPC-3 ([@R23]) ([@R2]) suggest the possibility of sampling errors and recommend that caution should be taken in the interpretation of immunohistochemical data concerning HCC.
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